Watson Pharmaceuticals has strengthened its commercial presence in Australia and Southeast Asia by acquiring the Ascent Pharmahealth generic pharmaceutical business of India’s Strides Arcolab for AUS$375 M (US$394 M) in cash. The acquisition has made Watson the largest generic drug maker in Singapore and the fifth largest generic pharmaceutical company in Australia in terms of revenue.